Hedge Fund - Cormorant Asset Management
Apellis Pharmaceuticals Inc. (APLS)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q2 (2024-06-30) | $0 | 0% | 0 | $45.29 |
| 2 | 2024 - Q1 (2024-03-31) | $23,512,000 | 1.03% | 400,000 | $63.75 |
| 3 | 2023 - Q4 (2023-12-31) | $37,412,500 | 1.78% | 625,000 | $50.73 |
| 4 | 2023 - Q3 (2023-09-30) | $76,080,000 | 4.43% | 2,000,000 | $43.93 |
| 5 | 2023 - Q2 (2023-06-30) | $119,341,000 | 6.68% | 1,310,000 | $86.28 |
| 6 | 2023 - Q1 (2023-03-31) | $89,706 | 5.9% | 1,360,000 | $57.70 |
| 7 | 2022 - Q4 (2022-12-31) | $81,540 | 5.45% | 1,576,872 | $53.04 |
| 8 | 2022 - Q3 (2022-09-30) | $100,947,000 | 7.05% | 1,478,000 | $59.17 |
| 9 | 2022 - Q2 (2022-06-30) | $42,959,000 | 3.24% | 950,000 | $45.59 |
| 10 | 2022 - Q1 (2022-03-31) | $57,161,000 | 4.38% | 1,125,000 | $44.15 |
| 11 | 2021 - Q4 (2021-12-31) | $29,550,000 | 1.75% | 625,000 | $39.37 |
| 12 | 2021 - Q3 (2021-09-30) | $30,488,000 | 1.23% | 925,000 | $56.19 |
| 13 | 2021 - Q2 (2021-06-30) | $53,720,000 | 1.82% | 850,000 | $51.60 |
| 14 | 2021 - Q1 (2021-03-31) | $80,075,000 | 1.78% | 1,866,108 | $47.32 |
| 15 | 2020 - Q4 (2020-12-31) | $106,741,000 | 2.54% | 1,866,108 | $42.30 |
| 16 | 2020 - Q3 (2020-09-30) | $56,300,000 | 2.16% | 1,866,108 | $29.88 |
| 17 | 2020 - Q2 (2020-06-30) | $67,479,000 | 2.57% | 2,066,108 | $32.11 |
| 18 | 2020 - Q1 (2020-03-31) | $60,709,000 | 2.82% | 2,266,108 | $35.50 |
| 19 | 2019 - Q4 (2019-12-31) | $82,674,000 | 3.29% | 2,700,000 | $27.68 |
| 20 | 2019 - Q3 (2019-09-30) | $71,692,000 | 4.36% | 2,976,000 | $27.52 |
| 21 | 2019 - Q2 (2019-06-30) | $75,161,000 | 4.31% | 2,966,108 | $20.35 |
| 22 | 2019 - Q1 (2019-03-31) | $70,200,000 | 4.74% | 3,600,000 | $15.73 |
| 23 | 2018 - Q4 (2018-12-31) | $59,388,000 | 4.82% | 4,502,498 | $15.34 |
| 24 | 2018 - Q3 (2018-09-30) | $74,187,000 | 4.82% | 4,172,498 | $18.48 |
| 25 | 2018 - Q2 (2018-06-30) | $94,875,000 | 7.02% | 4,312,498 | $22.98 |
| 26 | 2018 - Q1 (2018-03-31) | $90,390,000 | 6.73% | 4,088,229 | $19.65 |
| 27 | 2017 - Q4 (2017-12-31) | $81,782,000 | 8.56% | 3,768,757 | $14.72 |
The displayed share prices are average quarterly stock market prices.